In many cases of epilepsy—a disorder that disrupts the normal pattern of electrical activity in the brain and often results in seizures—the underlying cause is unknown, according to the National Institute of Neurological ...
Jul 7, 2022
0
53
There is currently no cure for Parkinson's disease (PD), and one of the main difficulties for developing treatments is that we don't know exactly how or why the disease occurs. It's generally believed that a buildup of Lewy ...
Jul 5, 2022
0
38
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.
Jun 13, 2022
0
7
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common form of motor neuron disease. People with ALS progressively lose the ability to initiate and control muscle movements, including ...
May 27, 2022
0
92
Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced ...
May 25, 2022
0
85
What did Stephen Hawking and Mao Zedong have in common? They both suffered from amyotrophic lateral sclerosis (ALS), for which a cure remains elusive. Scientists from Osaka Metropolitan University took an important step toward ...
May 23, 2022
0
18
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease that affects about 1 in 50,000 people. Well-known people who suffered from ALS include baseball player Lou Gehrig, who lived two years after he was ...
Apr 13, 2022
0
6
Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.
Mar 31, 2022
0
2
Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for amyotrophic lateral sclerosis (ALS).
Mar 30, 2022
0
14
Researchers of the Neuroplasticity and Regeneration Group of the Universitat Autònoma de Barcelona (UAB) and of the Functional Unit for Amyotrophic Lateral Sclerosis at the Hospital del Mar have identified the presence of ...
Mar 24, 2022
0
7
